Skip to main content

Hyperion records positive growth but rules out IPO in short-term

David Howden

Hyperion Insurance Group today reported a 51% increase in revenue for the year ended 30 September 2013 as group chief executive David Howden said an IPO is still firmly on the company’s agenda.

Group revenue rose from £111m in 2012 to £166.6m which contributed to a compound annual growth rate of 35% over the past five years.

Group ebitda increased by 74% to £35.9m from £20.6m in 2012

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Throwback Thursday: Biba’s talent help

Insurance Post’s Throwback Thursday steps back in time to September 1981 to remind you what was going on this week in insurance history when the British Insurance Brokers’ Association responded to demand from members for help with “personnel matters.”

McGill sold to EQT for $2bn

McGill and Partners and private equity firm EQT have entered into a definitive agreement in which the latter will acquire a majority stake in the former for $2bn (£1.5m).

AI in broking: why the debate must move on

For insurance brokers, Andy Lewis, head of people proposition at Hedron Network, says the artificial intelligence debate has shifted from whether to adopt the technology to how to embed it safely, practically and strategically so it delivers lasting value.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here